Bristol-Myers Squibb: A registered phase 2 QUINTESSENTIAL trial of a potential first-of-its-kind drug yielded positive top-line results.

Zhitongcaijing · 1d ago
Bristol-Myers Squibb: A registered phase 2 QUINTESSENTIAL trial of a potential first-of-its-kind drug yielded positive top-line results.